These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17249651)

  • 21. Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands.
    Ziemek R; Brennauer A; Schneider E; Cabrele C; Beck-Sickinger AG; Bernhardt G; Buschauer A
    Eur J Pharmacol; 2006 Dec; 551(1-3):10-8. PubMed ID: 17027743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and biological evaluation of a bivalent micro opiate and adenosine A1 receptor antagonist.
    Mathew SC; Ghosh N; By Y; Berthault A; Virolleaud MA; Carrega L; Chouraqui G; Commeiras L; Condo J; Attolini M; Gaudel-Siri A; Ruf J; Parrain JL; Rodriguez J; Guieu R
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6736-9. PubMed ID: 19836950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Affinity prediction on A1 adenosine receptor agonists: the chemometric approach.
    Fossa P; Mosti L; Bondavalli F; Schenone S; Ranise A; Casolino C; Forina M
    Bioorg Med Chem; 2006 Mar; 14(5):1348-63. PubMed ID: 16263293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5'-C-Ethyl-tetrazolyl-N(6)-substituted adenosine and 2-chloro-adenosine derivatives as highly potent dual acting A1 adenosine receptor agonists and A3 adenosine receptor antagonists.
    Petrelli R; Torquati I; Kachler S; Luongo L; Maione S; Franchetti P; Grifantini M; Novellino E; Lavecchia A; Klotz KN; Cappellacci L
    J Med Chem; 2015 Mar; 58(5):2560-6. PubMed ID: 25699637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and characterization of the first fluorescent antagonists for human 5-HT4 receptors.
    Berque-Bestel I; Soulier JL; Giner M; Rivail L; Langlois M; Sicsic S
    J Med Chem; 2003 Jun; 46(13):2606-20. PubMed ID: 12801225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists.
    Chang LC; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Westerhout J; Spangenberg T; Brussee J; Ijzerman AP
    J Med Chem; 2007 Feb; 50(4):828-34. PubMed ID: 17300165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of [3H]LUF5834: A novel non-ribose high-affinity agonist radioligand for the adenosine A1 receptor.
    Lane JR; Klaasse E; Lin J; van Bruchem J; Beukers MW; Ijzerman AP
    Biochem Pharmacol; 2010 Oct; 80(8):1180-9. PubMed ID: 20599769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analysis of putative agonist-binding modes in the human A1 adenosine receptor.
    Gutiérrez-de-Terán H; Pastor M; Centeno NB; Aqvist J; Sanz F
    Chembiochem; 2004 Jun; 5(6):841-9. PubMed ID: 15174168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [3H]HEMADO--a novel tritiated agonist selective for the human adenosine A3 receptor.
    Klotz KN; Falgner N; Kachler S; Lambertucci C; Vittori S; Volpini R; Cristalli G
    Eur J Pharmacol; 2007 Feb; 556(1-3):14-8. PubMed ID: 17126322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A highly conserved tryptophan residue in the fourth transmembrane domain of the A adenosine receptor is essential for ligand binding but not receptor homodimerization.
    Suzuki T; Namba K; Yamagishi R; Kaneko H; Haga T; Nakata H
    J Neurochem; 2009 Aug; 110(4):1352-62. PubMed ID: 19558453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allosteric modulators of the adenosine A1 receptor: synthesis and pharmacological evaluation of 4-substituted 2-amino-3-benzoylthiophenes.
    Aurelio L; Valant C; Flynn BL; Sexton PM; Christopoulos A; Scammells PJ
    J Med Chem; 2009 Jul; 52(14):4543-7. PubMed ID: 19514747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a red-emitting fluorescent ligand for in vitro visualization of human serotonin 5-HT(1A) receptors.
    Lacivita E; Masotti AC; Jafurulla M; Saxena R; Rangaraj N; Chattopadhyay A; Colabufo NA; Berardi F; Perrone R; Leopoldo M
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6628-32. PubMed ID: 20888762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2,4,6-trisubstituted pyrimidines as a new class of selective adenosine A1 receptor antagonists.
    Chang LC; Spanjersberg RF; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; van den Hout G; Beukers MW; Brussee J; Ijzerman AP
    J Med Chem; 2004 Dec; 47(26):6529-40. PubMed ID: 15588088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorescent pirenzepine derivatives as potential bitopic ligands of the human M1 muscarinic receptor.
    Tahtaoui C; Parrot I; Klotz P; Guillier F; Galzi JL; Hibert M; Ilien B
    J Med Chem; 2004 Aug; 47(17):4300-15. PubMed ID: 15294002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N(6)-[(hetero)aryl/(cyclo)alkyl-carbamoyl-methoxy-phenyl]-(2-chloro)-5'-N-ethylcarboxamido-adenosines: the first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor.
    Baraldi PG; Preti D; Tabrizi MA; Fruttarolo F; Saponaro G; Baraldi S; Romagnoli R; Moorman AR; Gessi S; Varani K; Borea PA
    Bioorg Med Chem; 2007 Apr; 15(7):2514-27. PubMed ID: 17306548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological evaluation of a new series of 2,3,5-substituted [1,2,4]-thiadiazoles as modulators of adenosine A1 receptors and their molecular mechanism of action.
    Göblyös A; de Vries H; Brussee J; Ijzerman AP
    J Med Chem; 2005 Feb; 48(4):1145-51. PubMed ID: 15715480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dye-labeled benzodiazepines: development of small ligands for receptor binding studies using fluorescence correlation spectroscopy.
    Hegener O; Jordan R; Häberlein H
    J Med Chem; 2004 Jul; 47(14):3600-5. PubMed ID: 15214787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2,6-disubstituted and 2,6,8-trisubstituted purines as adenosine receptor antagonists.
    Chang LC; Spanjersberg RF; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Brussee J; Ijzerman AP
    J Med Chem; 2006 May; 49(10):2861-7. PubMed ID: 16686529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, biological activity and molecular modelling of new trisubstituted 8-azaadenines with high affinity for A1 adenosine receptors.
    Giorgi I; Bianucci AM; Biagi G; Livi O; Scartoni V; Leonardi M; Pietra D; Coi A; Massarelli I; Nofal FA; Fiamingo FL; Anastasi P; Giannini G
    Eur J Med Chem; 2007 Jan; 42(1):1-9. PubMed ID: 17028066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and pharmacological evaluation of dual acting antioxidant A(2A) adenosine receptor agonists.
    Hausler NE; Devine SM; McRobb FM; Warfe L; Pouton CW; Haynes JM; Bottle SE; White PJ; Scammells PJ
    J Med Chem; 2012 Apr; 55(7):3521-34. PubMed ID: 22432713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.